Check that the expiration date has not passed and that the liquid is clear or slightly yellow
Important: The information provided here is for general guidance and should not replace professional medical advice
For a broader look at the journey, visit our complete guide to weight loss on GLP-1 medicines
Because lecanemab and donanemab have been approved relatively recently (in 2023 and 2024, respectively), their effectiveness beyond the length of their 18month clinical trials has not yet been fully established
Different Kinds of Peptides and Their Effect on Adrenal Fatigue Syndrome Adrenal Fatigue Syndrome (AFS) is a chronic condition that manifests as multiple nonspecific symptoms such as fatigue, exercise intolerance, reactive hypoglycemia, low blood pressure, insomnia, anxiety, or GI disruption that vary in severity and effect
Ready to transform your health